Anthony E Chiodo1, April Saval. 1. University of Michigan Medical Center, Ann Arbor, MI, USA. tchiodo@med.umich.edu
Abstract
CONTEXT/ OBJECTIVE: To demonstrate the utility of intrathecal baclofen in the treatment of secondary myoclonus of spinal origin. DESIGN: Case series. SETTING: University medical center. PARTICIPANTS: Two patients with spinal myoclonus who required the use of an assistive device because of difficulty walking resulting in falls. INTERVENTIONS: Intrathecal baclofen management. OUTCOME MEASURES: Symptom management and mobility function. RESULTS: Both experienced resolution of their spinal myoclonus and became community-level ambulators without the need of an assistive device. CONCLUSION: Intrathecal baclofen is an effective treatment of secondary myoclonus of spinal origin.
CONTEXT/ OBJECTIVE: To demonstrate the utility of intrathecal baclofen in the treatment of secondary myoclonus of spinal origin. DESIGN: Case series. SETTING: University medical center. PARTICIPANTS: Two patients with spinal myoclonus who required the use of an assistive device because of difficulty walking resulting in falls. INTERVENTIONS: Intrathecal baclofen management. OUTCOME MEASURES: Symptom management and mobility function. RESULTS: Both experienced resolution of their spinal myoclonus and became community-level ambulators without the need of an assistive device. CONCLUSION: Intrathecal baclofen is an effective treatment of secondary myoclonus of spinal origin.
Authors: C Stayer; V Tronnier; J Dressnandt; E Mauch; G Marquardt; K Rieke; G Müller-Schwefe; F Schumm; H M Meinck Journal: Neurology Date: 1997-12 Impact factor: 9.910